Scott Braunstein, SVP, Strategy & Corporate Development at Pacira Pharmaceuticals, Inc. (PCRX), sold 768 shares at $43.32 ($33K) on 2017-06-05, disclosed to the SEC on 2017-06-07.
Open-market sale of $33k PCRX by SVP, Strategy & Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRNS | SELL | 2024-02-21 | $118K | — | Filing → |
| MRNS | SELL | 2023-08-08 | $123K | — | Filing → |
| MRNS | BUY | 2019-12-13 | $125K | — | Filing → |